{
    "clinical_study": {
        "@rank": "132865", 
        "acronym": "STHYM", 
        "arm_group": [
            {
                "arm_group_label": "DBS", 
                "arm_group_type": "Experimental", 
                "description": "The medical device includes:\nEither a pacemaker ACTIVA PC (Ref 37601) two-channel (Medtronic USA) or two pacemakers Activa SC (Ref 37603) to a channel (Medtronic USA)\nTwo DBS electrodes with four contacts (type Medtronic DBS 3389). Patients will be operated with the usual stereotactic surgical procedure.\nThe target is the Accumbens nucleus.\nThe two electrodes are implanted in a single session under local anaesthesia or intermittent sedation (propofol parenteral without intubation early intervention). Day 0 is defined by the surgery.\nThe DBS is \"on\" during 6 months (between Month 1 and Month 7). Stimulation will also be on after Month 7."
            }, 
            {
                "arm_group_label": "SHAM", 
                "arm_group_type": "Sham Comparator", 
                "description": "The medical device includes:\nEither a pacemaker ACTIVA PC (Ref 37601) two-channel (Medtronic USA) or two pacemakers Activa SC (Ref 37603) to a channel (Medtronic USA)\nTwo DBS electrodes with four contacts (type Medtronic DBS 3389). Patients will be operated with the usual stereotactic surgical procedure.\nThe target is the Accumbens nucleus.\nThe two electrodes are implanted in a single session under local anaesthesia or intermittent sedation (propofol parenteral without intubation early intervention). Day 0 is defined by the surgery.\nThe DBS is \"off\" during 6 months (between Month 1 and Month 7). Possibility to active the stimulation after Month 7."
            }
        ], 
        "brief_summary": {
            "textblock": "Major depressive disorders are real public health issues in terms of diagnosis and\n      treatment. Some forms of depression are chronic and resistant to treatment (TRD). In these\n      forms suicide risk is important.\n\n      Patients with TRD are potential candidates for neurosurgical interventions to treat\n      depression. However, psychosurgery interventions based upon lesions, showed their\n      limitations related to 1. the large variability in neurosurgical gestures, 2. their side\n      effects, and of course 3. the irreversible damage caused by the surgery.\n\n      Thus, deep brain stimulation (DBS) could represent an opportunity for patients suffering\n      from TRD. Our preliminary study based upon the stimulation of the accumbens nucleus showed\n      encouraging results. The investigators have thus planned a randomized controlled trial\n      versus sham stimulation to confirm the therapeutic value of nucleus accumbens DBS."
        }, 
        "brief_title": "Deep Brain Stimulation in Patients With Chronic Treatment Resistant Depression", 
        "completion_date": {
            "#text": "February 2020", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Major Depressive Disorder", 
            "Recurrent Depressive Disorder", 
            "Bipolar Disorder"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Bipolar Disorder", 
                "Depression", 
                "Depressive Disorder", 
                "Depressive Disorder, Major"
            ]
        }, 
        "detailed_description": {
            "textblock": "Because of their recurrent nature, their prevalence and their consequences, major depressive\n      disorders are real public health issues in terms of diagnosis and treatment.\n\n      Some forms of depression are chronic and resistant to treatment (TRD), either unipolar\n      (repeated episodes of depression) or bipolar (repeated episodes of depression and manic\n      and/or hypomanic episodes). In these forms suicide risk is important.\n\n      Patients with TRD are potential candidates for neurosurgical interventions to treat\n      depression. The benefit of neurosurgical procedures is expected to be important in these\n      patients.\n\n      Psychosurgery interventions based upon lesions, however, showed their limitations related to\n      1/ the large variability in neurosurgical gestures, 2/ their side effects, and of course 3/\n      the irreversible damage caused by the surgery.\n\n      Current brain imaging data yielded fresh information about the pathophysiology of depression\n      and suggested new therapeutic approaches in TRD.\n\n      Modulation of sub-caudate specific pathways, which are part of orbitofrontal and anterior\n      cingulate cortico-subcortical loops should allow for a diminution of depressive symptoms.\n\n      The modulation of these specific pathways, initially targeted by classical neurosurgery,\n      could benefit from current developments in functional neurosurgery.\n\n      Deep brain stimulation (DBS) may represent an opportunity for patients suffering from TRD.\n      Our preliminary study based upon the stimulation of the accumbens nucleus showed encouraging\n      results. The investigators have thus planned a  randomized controlled trial versus sham\n      stimulation to confirm the therapeutic value of nucleus accumbens DBS."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age between 18 and 70 years\n\n          -  DSM-IV (DSM = Diagnostic and Statistical Manual) criteria for a recurrent depressive\n             disorder or bipolar disorder\n\n          -  Duration of the episode > 2 years\n\n          -  Severity of the episode attested by :\n\n               -  A HDRS score > 21\n\n               -  A CGI score \u2265 4\n\n               -  A GAF < 50\n\n          -  Persistence of severity criteria during the screening\n\n          -  Following characteristics resistance in case of recurrent depressive disorder :\n\n               -  Stage V of the classification of Thase and Rush\n\n               -  Unsuccessful treatment by the association of two antidepressants (or\n                  intolerance/contra-indications)\n\n               -  Unsuccessful treatment by the association for at least 6 weeks of one of the\n                  following treatments : lithium , thyroid hormone , buspirone , pindolol with an\n                  antidepressant (or intolerance/contra-indications)\n\n               -  Unsuccessful treatment by the combination of a second-generation antipsychotic\n                  (olanzapine, risperidone, amisulpride, aripiprazole, clozapine and quetiapine)\n                  to an antidepressant (or intolerance/contra-indications)\n\n               -  Unsuccessful treatment by a structured psychotherapy\n\n          -  Following characteristics of resistance in case of bipolar disorder:\n\n               -  Unsuccessful treatment by lithium (or intolerance/contra-indications)\n\n               -  Unsuccessful treatment by at least one mood stabilizer anticonvulsant (or\n                  intolerance/contra-indications)\n\n               -  Unsuccessful treatment by at least one second-generation antipsychotic (or\n                  intolerance/contra-indications)\n\n               -  Unsuccessful treatment by the combination of two mood stabilizers with at least\n                  an anticonvulsant (or intolerance/contra-indications)\n\n               -  Unsuccessful treatment by electro-convulsive therapy sessions (or\n                  intolerance/contra-indications)\n\n               -  Unsuccessful treatment by at least one antidepressant , mood stabilizer\n                  combination (or intolerance/contra-indications)\n\n               -  Unsuccessful treatment by a structured psychotherapy\n\n          -  Understanding the conduct of the study\n\n          -  Giving a written informed consent\n\n          -  Benefiting from the french social insurance\n\n        Non-Inclusion Criteria:\n\n          -  Comorbid axis 1 disorder (except dysthymia, generalized anxiety disorder, social\n             phobia, panic disorder)\n\n          -  Alcohol or other psychoactive substances dependence (except nicotine)\n\n          -  Suicidal risk during the last month assessed by the MINI (Mini International\n             Neuropsychiatric Interview), the DIGS (Diagnostic Interview for Genetic Studies) and\n             the item 3 of the HDRS\n\n          -  Suicide attempt in the last 6 months or two suicide attempts in the previous two\n             years\n\n          -  History of forensic act or furious mania\n\n          -  Depressive episode with congruent or incongruent  psychotic features or history of a\n             depressive episode with psychotic features\n\n          -  Comorbid cluster A or B personality disorders according to the DSM IV-TR evaluated\n             using the SCID2 (Structured Clinical Interview for DSM-IV)\n\n          -  Cognitive Impairment (Mattis < 130)\n\n          -  MRI (Magnetic Resonance Imaging) contraindication to stimulation or contraindications\n             for MRI\n\n          -  Major somatic disease making it impossible to set up the study treatment\n\n          -  Pregnant women, or nursing or childbearing potential without effective contraception\n\n          -  Involuntary commitment\n\n          -  Guardianship\n\n          -  Participation in another study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01973478", 
            "org_study_id": "191-STHYM"
        }, 
        "intervention": [
            {
                "arm_group_label": "DBS", 
                "intervention_name": "DBS", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "SHAM", 
                "intervention_name": "SHAM", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Major depressive disorder", 
            "Recurrent depressive disorder", 
            "Bipolar disorder", 
            "Deep brain stimulation", 
            "Accumbens"
        ], 
        "lastchanged_date": "May 27, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Bruno AOUIZERATE"
                }, 
                "facility": {
                    "address": {
                        "city": "Bordeaux", 
                        "country": "France"
                    }, 
                    "name": "CHU"
                }, 
                "investigator": {
                    "last_name": "Bruno AOUIZERATE", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Isabelle JALENQUES"
                }, 
                "facility": {
                    "address": {
                        "city": "Clermont Ferrand", 
                        "country": "France"
                    }, 
                    "name": "CHU"
                }, 
                "investigator": {
                    "last_name": "Isabelle JALENQUES", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Mircea POLOSAN"
                }, 
                "facility": {
                    "address": {
                        "city": "Grenoble", 
                        "country": "France"
                    }, 
                    "name": "CHU"
                }, 
                "investigator": {
                    "last_name": "Mircea POLOSAN", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Maxime BUBROVSZKY"
                }, 
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France"
                    }, 
                    "name": "CHU"
                }, 
                "investigator": {
                    "last_name": "Maxime BUBROVSZKY", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Fr\u00e9d\u00e9ric HAESEBAERT"
                }, 
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France"
                    }, 
                    "name": "CH Le Vinatier"
                }, 
                "investigator": {
                    "last_name": "Fr\u00e9d\u00e9ric HAESEBAERT", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Christophe LANCON"
                }, 
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France"
                    }, 
                    "name": "APHM"
                }, 
                "investigator": {
                    "last_name": "Christophe LANCON", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Raymund SCHWAN"
                }, 
                "facility": {
                    "address": {
                        "city": "Nancy", 
                        "country": "France"
                    }, 
                    "name": "CHU"
                }, 
                "investigator": {
                    "last_name": "Raymund SCHWAN", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Jean-Marie VANELLE"
                }, 
                "facility": {
                    "address": {
                        "city": "Nantes", 
                        "country": "France"
                    }, 
                    "name": "CHU"
                }, 
                "investigator": {
                    "last_name": "Jean Marie VANELLE", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Bruno GIORDANA"
                }, 
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France"
                    }, 
                    "name": "CHU"
                }, 
                "investigator": {
                    "last_name": "Bruno GIORDANA", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Marie-Odile KREBS"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France"
                    }, 
                    "name": "CH Sainte Anne"
                }, 
                "investigator": {
                    "last_name": "Marie-Odile KREBS", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Philippe FOSSATI"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France"
                    }, 
                    "name": "APHP Piti\u00e9 Salpetriere"
                }, 
                "investigator": {
                    "last_name": "Philippe FOSSATI", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Nematollah JAAFARI"
                }, 
                "facility": {
                    "address": {
                        "city": "Poitiers", 
                        "country": "France"
                    }, 
                    "name": "CHS"
                }, 
                "investigator": {
                    "last_name": "Nematollah JAAFARI", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Bruno MILLET"
                }, 
                "facility": {
                    "address": {
                        "city": "Rennes", 
                        "country": "France"
                    }, 
                    "name": "CHGR"
                }, 
                "investigator": {
                    "last_name": "Bruno MILLET", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Olivier GUILLIN"
                }, 
                "facility": {
                    "address": {
                        "city": "Rouen", 
                        "country": "France"
                    }, 
                    "name": "CHS"
                }, 
                "investigator": {
                    "last_name": "Olivier GUILLIN", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Christophe ARBUS"
                }, 
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France"
                    }, 
                    "name": "CHU"
                }, 
                "investigator": {
                    "last_name": "Christophe ARBUS", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Deep Brain Stimulation in Patients With Chronic Treatment Resistant Depression", 
        "other_outcome": [
            {
                "description": "Longitudinal evolution of the score", 
                "measure": "HDRS-17 (Hamilton depression rating scale, 17 items version)", 
                "safety_issue": "No", 
                "time_frame": "Month -3 ; Month -1; Day -7; Day 15; Month 1; Day 45; Month 2 ; Day 75 ;  Month 3; Month 4; Month 5; Month 6; Month 7; Month 8; Month 9; Month 10; Month 13; Month 16; Month 19; Month 22; Month 24"
            }, 
            {
                "description": "Longitudinal evolution of the score", 
                "measure": "MADRS (Montgomery-Asberg Depression Rating Scale)", 
                "safety_issue": "No", 
                "time_frame": "Month -3 ; Month -1; Day -7; Day 15; Month 1; Day 45; Month 2 ; Day 75 ;  Month 3; Month 4; Month 5; Month 6; Month 7; Month 8; Month 9; Month 10; Month 13; Month 16; Month 19; Month 22; Month 24"
            }, 
            {
                "description": "Longitudinal evolution of the score", 
                "measure": "BDI (Beck Depression Inventory)", 
                "safety_issue": "No", 
                "time_frame": "Day -7; Day 15; Month 1; Day 45; Month 2 ; Day 75 ;  Month 3; Month 4; Month 5; Month 6; Month 7; Month 8; Month 9; Month 10; Month 13; Month 16; Month 19; Month 22; Month 24"
            }, 
            {
                "description": "Longitudinal evolution of the score", 
                "measure": "CGI (Clinical global impressions)", 
                "safety_issue": "No", 
                "time_frame": "Month -3 ; Month -1; Day-7; Day15; Month 1; Day 45; Month 2 ; Day 75 ;  Month 3; Month 4; Month 5; Month 6; Month 7; Month 8; Month 9; Month 10; Month 13; Month 16; Month 19; Month 22; Month 24"
            }, 
            {
                "description": "Longitudinal evolution of the score", 
                "measure": "LARS (Lille Apathy Rating scale)", 
                "safety_issue": "No", 
                "time_frame": "Day -7; Month 1; Month 7; Month 13; Month 19; Month 24"
            }, 
            {
                "description": "Longitudinal evolution of the score", 
                "measure": "GAF (Global assessment of functioning)", 
                "safety_issue": "No", 
                "time_frame": "Month -3 ; Month -1; Day -7; Month 1; Month 7; Month 13; Month 19; Month 24"
            }, 
            {
                "description": "Longitudinal evolution of the score", 
                "measure": "YMRS (Young Mania Rating Scale)", 
                "safety_issue": "No", 
                "time_frame": "Day -7; Month 1; Month 7; Month 13; Month 19; Month 24"
            }, 
            {
                "description": "Longitudinal evolution of the score", 
                "measure": "MATHYS (Multidimensional Assessment of Thymic States)", 
                "safety_issue": "No", 
                "time_frame": "Day -7; Month 1; Month 7; Month 13; Month 19; Month 24"
            }, 
            {
                "description": "During the whole follow up", 
                "measure": "Response (50 % decrease of the HDRS-17)", 
                "safety_issue": "No", 
                "time_frame": "Month 24"
            }, 
            {
                "description": "During the whole follow up Remission is defined as an HDRS-17 score < 7", 
                "measure": "Remission", 
                "safety_issue": "No", 
                "time_frame": "M24"
            }
        ], 
        "overall_contact": {
            "email": "bruno.millet@univ-rennes1.fr", 
            "last_name": "Bruno Millet", 
            "phone": "(0)299333937"
        }, 
        "overall_official": [
            {
                "affiliation": "CIC INSERM 0203 CHU Rennes", 
                "last_name": "Jean Michel Reymann", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "CIC INSERM 0203 CHU Rennes", 
                "last_name": "Florian Naudet", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Rennes University Hospital", 
                "last_name": "Bruno Millet", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "March 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Response is defined as a 50 % decrease of the HDRS-17 (Hamilton depression rating scale, 17 items version)", 
            "measure": "Response = 50 % decrease of the HDRS-17 (Hamilton depression rating scale, 17 items version) (yes/no)", 
            "safety_issue": "No", 
            "time_frame": "Month 7"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01973478"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Remission is defined as an HDRS-17 score < 7", 
                "measure": "Remission (yes/no)", 
                "safety_issue": "No", 
                "time_frame": "Month 7"
            }, 
            {
                "description": "Score of 1 or 2 (item 2 of the CGI)", 
                "measure": "CGI (Clinical global impressions) amelioration (yes/no)", 
                "safety_issue": "No", 
                "time_frame": "Month 7"
            }, 
            {
                "description": "Presence of a score \u2265 60", 
                "measure": "GAF (Global assessment of functioning)", 
                "safety_issue": "No", 
                "time_frame": "Month 7"
            }, 
            {
                "description": "Score", 
                "measure": "HDRS-17 (Hamilton depression rating scale, 17 items version)", 
                "safety_issue": "No", 
                "time_frame": "Month 7"
            }, 
            {
                "description": "Score", 
                "measure": "MADRS (Montgomery-Asberg Depression Rating Scale)", 
                "safety_issue": "No", 
                "time_frame": "Month 7"
            }, 
            {
                "description": "Score", 
                "measure": "BDI (Beck Depression Inventory)", 
                "safety_issue": "No", 
                "time_frame": "Month 7"
            }, 
            {
                "description": "Score", 
                "measure": "CGI (Clinical global impressions)", 
                "safety_issue": "No", 
                "time_frame": "Month 7"
            }, 
            {
                "description": "Score", 
                "measure": "LARS (Lille Apathy Rating scale)", 
                "safety_issue": "No", 
                "time_frame": "Month 7"
            }, 
            {
                "description": "Score", 
                "measure": "GAF (Global assessment of functioning)", 
                "safety_issue": "No", 
                "time_frame": "Month 7"
            }, 
            {
                "measure": "Neuropsychological assessment", 
                "safety_issue": "Yes", 
                "time_frame": "Day -7 ; Month 1; Month 7; Month 13; Month 19; Month 24"
            }, 
            {
                "measure": "Cerebral metabolism (PET scans)", 
                "safety_issue": "No", 
                "time_frame": "Day -7; Month 7"
            }, 
            {
                "description": "Adverse events occuring during the study.", 
                "measure": "Adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "Month 24"
            }
        ], 
        "source": "Rennes University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rennes University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}